Alterations in Vasopressin Mechanisms in Captopril-Treated Spontaneously Hypertensive Rats

References

• Crofton J T, Share L, Shade R E, Allen C, Tarnowski D. Vasopressin in the rat with spontaneous hypertension. Am J Physiol 1978; 234: H361–H366
   PubMedGoogle Scholar
• Morris M. Nyeurohypophyseal response to dehydration in the spontaneously hypertensive rat. Hypertension 1982; 4: 161–168
   PubMed Web of Science ®Google Scholar
• van Tol H HM, van den Buuse M, de Jong W, Burbach J PH. Vasopressin and oxytocin gene expression in supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension. Mol Brain Res. 1988; 4: 303–311
   Google Scholar
• DeVito W J, Miller M, Sutterer J R. Increased secretion of vasopressin and adenosine 3′, 5′-monophosphate from hypothalamo - posterior pituitary units of spontaneously hypertensive rats. Endocrinology 1982; 111: 1958–1963
   PubMed Web of Science ®Google Scholar
• Mohring J., Schoun J., Kintz J, Robinson I CAF, McNeill J R. Vasopressin and oxytocin content are decreased in the brain stems of spontaneously hypertensive rats. Neuroendocrinology 1983; 36: 457–461
   PubMed Web of Science ®Google Scholar
• Morris M, Ross J, Sundberg D K. Catecholamine biosynthesis and vasopressin and oxytocin secretion in the spontaneously hypertensive rat: an in vitro study of localized brain regions. Peptides. 1985; 6: 949–955
   PubMed Web of Science ®Google Scholar
• Negro-Vilar A, Saavedra J M. Changes in brain stem soniatostatin and vasopressin levels after stress in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull 1980; 5: 353–358
   PubMed Web of Science ®Google Scholar
• Rockhold R W, Crofton J T, Brooks D P, Share L. The response of vasopressin and blood pressure to hemorrhage in SHR and WKY rats. Clin Exp Hyp 1984; 6: 327–849
   Google Scholar
• Mohring J, Kintz J, Schoun J. Studies on the role of vasopressin in blood pressure control of spontaneously hypertensive rats with established hypertension (SHR, stroke prone strain). J Cardiovasc Pharmacol 1979; 593–608
   PubMed Web of Science ®Google Scholar
• Sladek C, Blair M, Sterling C, Mangiapane M. Attenuation of spontaneous hypertension in rats by a vasopressin antagonist. Hypertension 1988; 12: 506–512
   PubMed Web of Science ®Google Scholar
• Schelling P, Felix D. Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats. Hypertension 1983; 5: 935–942
   PubMed Web of Science ®Google Scholar
• Schelling P, Meyer D, Loos H E, Speck G, et al. A micromethod for the measurement of renin in brain nuclei: Its application in spontaneously hypertensive rats. Neuropharmacol 1982; 21: 455–463
   PubMed Web of Science ®Google Scholar
• Weyhenmeyer J A, Phillips M I. Angiotensin-like immunoreactivity in the brain of the spontaneously hypertensive rat. Hypertension 1982; 4: 514–523
   PubMed Web of Science ®Google Scholar
• Ganten D, Hermann K, Bayer C, Unger T, Lang R E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1983; 221: 869–871
   PubMed Web of Science ®Google Scholar
• Hermann K, Unger W., McDonald T, Lang R E, Ganten D. Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. J Physiol (Paris) 1984; 79: 4/1–480
   Google Scholar
• Raizada M K, Stenstrom B, Phillips M I, Summers C. Angiotensin II in neuronal cultures from brains of normotensive and hypertensive rats. Am J Physiol. 1984; 247: C115–C119
   PubMed Web of Science ®Google Scholar
• Casto R, Phillips M I. Neuropeptide action in nucleus tractus solitarius: Angiotensin specificity and hypertensive rats. Am J Physiol 1985; 249: R341–R347
   PubMed Web of Science ®Google Scholar
• Berecek K H, Okuno T, Nagahama T, Oparil S. Altered vascular reactivity and baroreflex sensitivity induced by chronic central adnistration of captopril in the spontaneously hypertensive rat. Hypertension 1983; 5: 689–700
   PubMed Web of Science ®Google Scholar
• Phillips M I, Mann J FE, Haebara H, Hoffman W E, et al. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature 1977; 270: 445–447
   PubMed Web of Science ®Google Scholar
• Unger T, Kaufman-Buhler I, Scholkens B A, Ganten D. Brain converting enzyme inhibition a possible mechanism for the antihypertensive action of captopril in: spontaneously hypertensive rats. Eur J Pharmacol. 1981; 70: 467–478
   PubMed Web of Science ®Google Scholar
• Unger T, Rockhold R W, Kaufmann-Buhler I, Hubner D., et al. Effects of converting enzyme inhibitors on the brain. Angiotensin Converting Enzyme Inhibitors: Mechanism of Action and Clinical Implications, Z P Horovitz. Urban and Schwarzenberg, Baltimore 1981; 55
   Google Scholar
• Wilson K M, Magargal W, Berecek K H. Long-term captopril treatment: Angiotensin II receptors and responses. Hypertension II 1988, Suppl I: I-148–I-152
   Google Scholar
• Gavras H, Hatzinkolaou R, North W G, Bresnaham M, Gavras I. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure. Hypertension 1982; 4: 400–405
   PubMed Web of Science ®Google Scholar
• Phillips M I. Brain angiotensin in vitro studies and a unifying hypothesis of hypertension. Brain Peptides and Catecholamines in Cardiovascular Regulation, J P Buckley, C M Ferrario. Raven Press, NY 1987; 273–287
   Google Scholar
• Reid J L, Rubin P C. Peptides and central neural regulation of the circulation. Physiol Rev 1987; 67: 725–749
   PubMed Web of Science ®Google Scholar
• Sawchenko P E, Swanson L W. A method for tracing biochemically defined pathways in the central nervous system using combined fluorescence, retrograde transport and immunohistochemical techniques. Brain Res 1981; 210: 31–51
   PubMed Web of Science ®Google Scholar
• Berecek K H, Work J, Mitchum T N, Ram S. Effects of chronic peripheral sympathectomy on plasma levels of, and the pressor response to, vasopressin. J. Hypertension 1985; 3: 225–230
   PubMed Web of Science ®Google Scholar
• Dorsa D M, Majundar L A, Petracca F M, Baskin D G, Cornett L E. Characterization and localization of 3H-arginine 8 vasopressin binding to rat kidney and brain tissue. Peptides 1983; 4: 699–706
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with folin phenol agent. J Biol Chem 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attraction of protein for small molecules in ions. Ann NY Acad Sci. 1949; 51: 660–672
   Web of Science ®Google Scholar
• Berecek K H, Okuno T, Nagahama T, Oparil S. Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat. Hypertension 1983; 5: 689–700
   PubMed Web of Science ®Google Scholar
• Morris M, Keller M, Sundberg D K. Changes in paraventricular vasopressin and oxytocin during the development of spontaneous hypertension. Hypertension 1983; 5: 476–481
   PubMed Web of Science ®Google Scholar
• Sladek C D, Armstrong W E. Effect of neurotransmitters and neuropeptides on vasopressin release. Vasopressin: Principles and Properties, D. M. Gash, G. J. Boer. Plenum Press, NY 1987; 275–333
   Google Scholar
• Cheng S WT, Wilson K M, Mulcahey J J, Stallworth J W, Berecek K H. Vasopressin in neuronal cultures from neonatal rat brain. Hypertension 1989; 13: 902–909
   PubMed Web of Science ®Google Scholar
• Crofton J T, Share L, Horovitz Z P. The effect of SQ 14, 225 on systolic blood pressure and urinary excretion of vasopressin in the developing hypertensive rat. Hypertension 1979; 1: 462–467
   PubMed Web of Science ®Google Scholar
• Thibonnier M., Soto M E, Menard J, Aldegir J C, et al. Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril. Europ J Clin Invest 1981; II: 449–453
   Google Scholar
• Berecek K H, Coshatt G, Narkates A J, Oparil S, et al. Brain angiotensin II and the response to stress in the spontaneously hypertensive rat. Hypertension II 1988, Suppl I: I-144–I-147
   Google Scholar
• Berecek K H, Swords B H. Central role for vasopressin in cardiovascular regulation and the pathogenesis of hypertension. Hypertension 1990; 16: 213–224
   PubMed Web of Science ®Google Scholar
• Backman S B, Henry J L. Effects of oxytocin and vasopressin on thoracic sympathetic preganglionic neurons in the cat. Brain Res Bull 1984; 13: 679–684
   PubMed Web of Science ®Google Scholar
• Nagahama T, Lindheimer M D, Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of Captopril. Hypertension 1983; 5: 653
   PubMed Web of Science ®Google Scholar
• Schrier R W, Berl T, Anderson R J. Osmotic and nonosmotic control of vasopressin release. AJP 1979; 236: F321–F332
   PubMed Web of Science ®Google Scholar
• Lind R W, Swanson L W, Garten D. Organization of angiotensin II immunoreactive cells and fibers in the rat nervous system. Neuroendocrinol 1985; 40: 2–24
   PubMed Web of Science ®Google Scholar
• Akaishi T, Negoro H, Kobayasi S. Electrophysiological evidence for multiple sites of actions of angiotensin II with stimulating paraventricular neurosecretory cells in the rat. Brain Res 1980; 188: 499–511
   PubMedGoogle Scholar
• Jirikowski G, Reisert I, Pilgrim C. Angiotensin II promotes development of neurophysin neurons in dissociated culture. Develop Brain Res 1984; 14: 179–183
   Google Scholar
• Fellx D, Schelling P. Angiotensin-converting enzyme blockade by captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-SP and WKY rats. Neuroscience Lett 1982; 34: 45–50
   PubMed Web of Science ®Google Scholar
• Hermann K, McDonald W, Unger T, Lang R E, Ganten D. Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. J Physiol (Paris) 1984; 79: 471–480
   PubMedGoogle Scholar
• Cornett L E. Vasopressin Receptors. Peptide Hormone Receptors, M Y Kalami, J R Hubbard. Walter de Gruyter and Co., New York 1987; 437–479
   Google Scholar